Clinical impact of metagenomic next-generation sequencing for pathogen identification and guided therapy in pediatric intensive care unit patients with severe pulmonary infections
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.00374-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Yuping Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of PICU, The First Affiliated Hospital of Henan Medical University, Henan, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Metagenomics, Bacteria, Pneumonia. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
To explore the diagnostic efficiency, clinical concordance, and precision treatment value of metagenomic next-generation sequencing (mNGS) for severe pulmonary infections in children in the pediatric intensive care unit (PICU), and to provide evidence for improving microbiological diagnosis and optimizing anti-infective strategies. A retrospective cohort study included 89 children with severe pneumonia in the PICU in 2024. All underwent routine microbiological testing and mNGS of bronchoalveolar lavage fluid (BALF). Detection rates, pathogen composition, co-infection identification, diagnostic concordance, and treatment impact were analyzed. Metagenomic next-generation sequencing demonstrated high diagnostic sensitivity in the PICU setting, achieving a positive detection rate of 90.0% (80/89) and identifying a diverse spectrum of 103 pathogens, including 50.5% viruses, 43.7% bacteria, 38.8% co-infections (vs 11.6%), and 86.3% diagnostic concordance (vs 55.8%, P < 0.01). Among 46 patients included in the therapeutic outcome analysis (22 in the mNGS-guided group), 21 patients in the mNGS-guided group improved. Multivariate logistic regression analysis, adjusting for confounding factors (age, underlying diseases, PaO 2 /FiO 2 ratio, PRISM III score, and preoperative antibiotic use duration), confirmed that mNGS-guided therapy was an independent protective factor for achieving the primary outcome (OR = 5.23, 95% CI: 1.87–14.61, P = 0.002) and secondary outcomes (C-reactive protein reduction ≥50%: OR = 4.89, 95% CI: 1.72–13.93, P = 0.003; oxygenation improvement: OR = 5.67, 95% CI: 1.98–16.21, P = 0.001). Metagenomic next-generation sequencing demonstrated high diagnostic sensitivity in the PICU setting, guiding precision therapy, and improving prognosis. IMPORTANCE It supports metagenomic next-generation sequencing (mNGS) as a supplementary tool for pediatric intensive care unit (PICU) refractory infections, guides anti-infective adjustments, and informs tiered diagnostic pathways for resource-limited settings to optimize cost-effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of PICU, The First Affiliated Hospital of Henan Medical University, Henan, China.
- Department of Pediatric Hematology and Oncology, Cardiovascular Diseases, The First Affiliated Hospital of Henan Medical University, Henan, China.
ORCID-Profile: Shujun Li
Zitieren
APA
Xu, Y., Ren, R., Liu, W., Liu, L., Cui, X., Guo, J., & Li, S. (2026). Clinical impact of metagenomic next-generation sequencing for pathogen identification and guided therapy in pediatric intensive care unit patients with severe pulmonary infections. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00374-26
Vancouver
Xu Y, Ren R, Liu W, Liu L, Cui X, Guo J, et al. Clinical impact of metagenomic next-generation sequencing for pathogen identification and guided therapy in pediatric intensive care unit patients with severe pulmonary infections. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00374-26
BibTeX
@article{Xu2026,
author = {Xu, Yuping and Ren, Ruijuan and Liu, Weiqing and Liu, Ling and Cui, Xinyan and Guo, Jia and Li, Shujun},
title = {Clinical impact of metagenomic next-generation sequencing for pathogen identification and guided therapy in pediatric intensive care unit patients with severe pulmonary infections},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.00374-26}
}
EUVIMED